131 results on '"Ang, K.K."'
Search Results
2. Motor imagery-assisted brain-computer interface for gait retraining in neurorehabilitation in chronic stroke
3. Reducing hydroelastic responses of pontoon-type VLFS using vertical elastic mooring lines
4. 2820 Association of p16 status and feeding tube use in patients with locoregionally advanced squamous cell cancer of the head and neck treated with radiotherapy +/- cetuximab in a phase III study
5. PD-036: Association of HPV/p16 status with efficacy and safety in pts with OPC in the phase 3 RT/cetuximab registration trial
6. OC-016: Patient reported outcomes (PRO) of RTOG 9003
7. Association of Human Papillomavirus (Hpv) and P16 Status with Efficacy and Safety Data in the Phase III Radiotherapy (Rt)/Cetuximab (Cet) Registration Trial for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (Lascchn)
8. Inhibition of IGF-1R Signaling Enhances the Head and Neck Tumor Radioresponse but Fails to Further Improve Tumor Response to Cetuximab and Radiation Therapy In Vivo
9. Numerical simulation of fully nonlinear wave interaction with submerged structures: Fixed or subjected to constrained motion
10. Modeling and simulation of buckling of embedded carbon nanotubes
11. Fully nonlinear analysis of near-trapping phenomenon around an array of cylinders
12. Comparison Between IMRT and 3D CRT in Laryngeal Cancer Patients Treated on RTOG 0522
13. A Phase 3 Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Long-term Report of Efficacy and Toxicity
14. Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines
15. SP-031: Update of R-TOG 0522. A Randomised Phase III Trial of Concurrent Accelerated Radiation and Cispltin Versus Concurrent Accelerated Radiation, Cisplatin and Cetuximab (C225) for State III and IV Head and Neck Carcinomas
16. Long-term Outcomes from RTOG 99-03: Radiation Therapy With or Without Erythropoietin for Anemic Head-and-Neck Cancer Patients
17. RTOG 90-03: Final Report
18. 317 Schedule Dependent Tumor Cell Response to Radiation When Combined with Anti-IGF1R and Anti-EGFR Antibodies
19. Real-time Peer Review Quality Assurance Conferences Incorporating Physical Examination for Head-and-Neck Cancer Radiation Therapy Result in Clinically Meaningful Target Volume Alteration: Results of a Prospective Volumetric Analysis
20. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
21. 311 TUMOR MICROENVIRONMENT AND INTEGRINS AS EFFECTIVE THERAPEUTIC TARGETS TO IMPROVE RADIOTHERAPY OUTCOME
22. 29 IMPACT OF EPITHELIAL-TO-MESENCHYMAL TRANSITION ON TUMOR RESPONSE TO RADIATION AND TARGETED AGENTS
23. 324 BIOMARKERS FOR HEAD AND NECK CARCINOMA
24. Supervised Pseudo Self-Evolving Cerebellar algorithm for generating fuzzy membership functions
25. IMRT for Oropharyngeal Carcinoma: Patient Outcomes and Patterns of Failure
26. United States Patterns of Radiation Oncology Practice in the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN) Study
27. Outcomes and Risk Factors in Patients Treated with Surgery and Postoperative Radiation Therapy Alone: A Subset Update of a Randomized Trial
28. A Gene Expression Signature Predicts Recurrence-free Survival and Overall Survival for High-risk Surgical-pathologic Head and Neck Squamous Cell Carcinomas following Post-operative Radiotherapy
29. Symptom Burden during Radiation Therapy and Chemoradiation for Head and Neck Cancer
30. Characteristics and Clinical Outcomes of Patients with Multiple Potentially HPV-Related Malignancies
31. A Phase II Study of Submandibular Salivary Gland Transfer to the Submental Space Prior to Start of Radiation Treatment for Prevention of Radiation-induced Xerostomia in Head and Neck Cancer Patients: Initial Report of RTOG – 0244
32. Should Hypopharynx Cancer Continue to be Included in ‘Multi-head and Neck’ Trials within the RTOG?
33. Skin Culture and Treatment Results in Head and Neck Cancer Patients with Severe Radiation Dermatitis and Potential Suprainfection
34. A higher-order plate element for accurate prediction of interlaminar stresses in laminated composite plates
35. Correlating Survival with Radiographic Response to Radiotherapy for Head-and-Neck Cancer Patients: FDG-PET/CT is not Superior to CT Alone
36. Pre- and Postinduction Chemotherapy Target Volume Delineation in Head and Neck Cancer: Preliminary Results from an Expert Panel
37. Phase II Randomized Trial of Postoperative Chemoradiation Plus Cetuximab for High-risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234)
38. Interfractional Movement of the Larynx and Oropharynx during Radiotherapy
39. Patterns of Disease Recurrence following Radiation for Oropharyngeal Cancer
40. Computation of stress resultants in plate bending problems using higher-order triangular elements
41. 351 POSTER Identification of kinases that are potential molecular determinants of cellular response to radiation using antibody arrays
42. Increased Oral Mucositis after IMRT versus Non-IMRT when Combined with Cetuximab and Cisplatin or Docetaxel for Head and Neck Cancer: Preliminary Results of RTOG 0234
43. Multi-institutional Trial of IMRT for Early Stage Oropharyngeal Cancer: Acceleration via Simultaneously Incorporated Boost (SIB) (RTOG 00-22)
44. Phase II Multi-institutional Study of Intensity Modulated Radiation Therapy (IMRT) +/− Chemotherapy for Nasopharyngeal (NPC) Carcinoma: Preliminary Clinical Results of RTOG 0225
45. Does FDG-PET/CT Provide Added Value over CT Alone for Assessment of Radiation Response in Advanced Stage Head and Neck Cancer?
46. Post-operative External Beam Radiotherapy for Differentiated Thyroid Cancer: Modern Era Outcomes and Morbidity
47. Buckling of super ellipsoidal shells under uniform pressure
48. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
49. Phase II Randomized Trial of Surgery Followed by Chemoradiation Plus Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234)
50. Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma Metastatic to Cervical Lymph Nodes From an Unknown Primary Site; Outcomes and Patterns of Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.